Neuroleptic malignant syndrome in a patient with Wilson's disease.
作者信息
Kontaxakis V, Stefanis C, Markidis M, Tserpe V
出版信息
J Neurol Neurosurg Psychiatry. 1988 Jul;51(7):1001-2. doi: 10.1136/jnnp.51.7.1001.
Abstract
摘要
相似文献
1
Neuroleptic malignant syndrome in a patient with Wilson's disease.一名威尔逊氏病患者的抗精神病药恶性综合征
J Neurol Neurosurg Psychiatry. 1988 Jul;51(7):1001-2. doi: 10.1136/jnnp.51.7.1001.
2
Neuroleptic malignant syndrome in a case of acute post-traumatic psychosis.
Br J Psychiatry. 1991 Aug;159:277-8. doi: 10.1192/bjp.159.2.277.
3
Successful use of clozapine in a patient with a history of neuroleptic malignant syndrome.氯氮平在有抗精神病药恶性综合征病史患者中的成功应用。
J Neuropsychiatry Clin Neurosci. 1989 Summer;1(3):303-5. doi: 10.1176/jnp.1.3.303.
4
Clozapine-induced neuroleptic malignant syndrome in an adolescent.氯氮平诱发青少年的抗精神病药恶性综合征。
J Child Adolesc Psychopharmacol. 2012 Aug;22(4):322-4. doi: 10.1089/cap.2011.0131.
5
[Psychiatric disorders treated with clozapine in a patient with Wilson's disease].[威尔逊病患者使用氯氮平治疗的精神障碍]
Presse Med. 2001 Apr 21;30(15):738.
6
The inadvisability of neuroleptic medication in Wilson's disease.
Biol Psychiatry. 1981 Oct;16(10):963-8.
7
Late-onset neuroleptic malignant syndrome in a patient using olanzapine.一名使用奥氮平的患者发生迟发性抗精神病药恶性综合征。
J Clin Psychopharmacol. 2007 Jun;27(3):303-4. doi: 10.1097/01.jcp.0000270093.39909.a9.
8
[The malignant neuroleptic syndrome].[恶性抗精神病药物综合征]
Nervenarzt. 1988 Dec;59(12):691-700.
9
Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.奥氮平诱发一名患有神经性厌食症的青少年男性出现非典型抗精神病药恶性综合征。
Eat Weight Disord. 2016 Jun;21(2):309-11. doi: 10.1007/s40519-015-0247-3. Epub 2015 Nov 25.
10
Neuroleptic malignant syndrome.
Biol Psychiatry. 1988 Dec;24(8):943-5. doi: 10.1016/0006-3223(88)90231-4.
引用本文的文献
1
Psychiatric Symptoms in Wilson's Disease-Consequence of Gene Mutations or Just Coincidence?-Possible Causal Cascades and Molecular Pathways.Wilson 病的精神症状——是基因突变的结果还是巧合？——可能的因果级联和分子途径。
Int J Mol Sci. 2024 Nov 18;25(22):12354. doi: 10.3390/ijms252212354.
2
Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.威尔逊病的精神症状：治疗的可能性与困难
Ther Adv Psychopharmacol. 2018 Jul;8(7):199-211. doi: 10.1177/2045125318759461. Epub 2018 Mar 6.
本文引用的文献
1
Neuroleptic malignant syndrome. Successful treatment with bromocriptine.
JAMA. 1983 Jan 21;249(3):386-8.
2
Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.
Arch Intern Med. 1982 Mar;142(3):601-3.
3
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.亨廷顿病患者因多巴胺耗竭药物引发的神经阻滞剂恶性综合征。
Neurology. 1981 Aug;31(8):1022-5. doi: 10.1212/wnl.31.8.1022.
4
Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?抗精神病药恶性综合征：多巴胺受体阻断的发病机制作用？
Neurology. 1981 Feb;31(2):132-7. doi: 10.1212/wnl.31.2.132.
5
The neuroleptic malignant syndrome.神经阻滞剂恶性综合征
J Clin Psychiatry. 1980 Mar;41(3):79-83.
6
Lithium carbonate, haloperidol, and irreversible brain damage.
JAMA. 1974 Dec 2;230(9):1283-7.
7
Neuroleptic malignant syndrome: review and analysis of 115 cases.抗精神病药恶性综合征：115例病例回顾与分析
Biol Psychiatry. 1987 Aug;22(8):1004-20. doi: 10.1016/0006-3223(87)90010-2.
8
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.一家大型精神病医院中抗精神病药恶性综合征的发生率及表现
Am J Psychiatry. 1986 Oct;143(10):1227-33. doi: 10.1176/ajp.143.10.1227.
9
The neuroleptic malignant syndrome: agent and host interaction.抗精神病药恶性综合征：药物与宿主的相互作用
Acta Psychiatr Scand. 1986 Apr;73(4):337-47. doi: 10.1111/j.1600-0447.1986.tb02694.x.
Zotero 插件